Widely available lysosome targeting agents should be considered as potential therapy for COVID-19

While the coronavirus disease 2019 (COVID-19) pandemic advances, the scientific community continues to struggle in the search for treatments. Several improvements have been made, including discovery of the clinical efficacy of chloroquine (CQ) in patients with COVID-19, but effective treatment proto...

Descripción completa

Detalles Bibliográficos
Autores principales: Homolak, J., Kodvanj, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. and International Society of Chemotherapy. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275137/
https://www.ncbi.nlm.nih.gov/pubmed/32522674
http://dx.doi.org/10.1016/j.ijantimicag.2020.106044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275137/
https://www.ncbi.nlm.nih.gov/pubmed/32522674
http://dx.doi.org/10.1016/j.ijantimicag.2020.106044

Ejemplares similares